AIRLINK 61.72 Decreased By ▼ -0.76 (-1.22%)
BOP 5.33 Decreased By ▼ -0.03 (-0.56%)
CNERGY 4.46 Decreased By ▼ -0.12 (-2.62%)
DFML 15.25 Decreased By ▼ -0.25 (-1.61%)
DGKC 65.00 Decreased By ▼ -1.40 (-2.11%)
FCCL 17.20 Decreased By ▼ -0.39 (-2.22%)
FFBL 27.50 Decreased By ▼ -0.20 (-0.72%)
FFL 9.30 Increased By ▲ 0.03 (0.32%)
GGL 10.00 Decreased By ▼ -0.06 (-0.6%)
HBL 104.98 Decreased By ▼ -0.72 (-0.68%)
HUBC 121.31 Decreased By ▼ -0.99 (-0.81%)
HUMNL 6.54 Decreased By ▼ -0.06 (-0.91%)
KEL 4.42 Decreased By ▼ -0.08 (-1.78%)
KOSM 4.43 Decreased By ▼ -0.05 (-1.12%)
MLCF 35.21 Decreased By ▼ -0.99 (-2.73%)
OGDC 122.00 Decreased By ▼ -0.92 (-0.75%)
PAEL 22.69 Decreased By ▼ -0.31 (-1.35%)
PIAA 31.54 Increased By ▲ 2.20 (7.5%)
PIBTL 5.83 Increased By ▲ 0.03 (0.52%)
PPL 107.04 Decreased By ▼ -0.46 (-0.43%)
PRL 27.15 Decreased By ▼ -0.10 (-0.37%)
PTC 17.85 Decreased By ▼ -0.22 (-1.22%)
SEARL 52.56 Decreased By ▼ -0.44 (-0.83%)
SNGP 62.62 Decreased By ▼ -0.59 (-0.93%)
SSGC 10.54 Decreased By ▼ -0.26 (-2.41%)
TELE 9.04 Decreased By ▼ -0.16 (-1.74%)
TPLP 11.37 Decreased By ▼ -0.07 (-0.61%)
TRG 69.94 Decreased By ▼ -0.92 (-1.3%)
UNITY 23.46 Decreased By ▼ -0.16 (-0.68%)
WTL 1.28 No Change ▼ 0.00 (0%)
BR100 6,914 Decreased By -29.8 (-0.43%)
BR30 22,631 Decreased By -195.8 (-0.86%)
KSE100 66,887 Decreased By -255.5 (-0.38%)
KSE30 22,011 Decreased By -78.9 (-0.36%)
World

Australia investigates possible link of blood clot case to AstraZeneca vaccine

  • Australian media reported that a 44-year-old man was admitted to a Melbourne hospital with possible clotting days after receiving the vaccine.
Published April 2, 2021

MELBOURNE: Australia is investigating whether a blood clotting disorder case recorded on Friday is related to the AstraZeneca coronavirus vaccine, Deputy Chief Medical Officer Professor Michael Kidd said.

Australian media reported that a 44-year-old man was admitted to a Melbourne hospital with possible clotting days after receiving the vaccine.

"Investigators have not at this time confirmed a causal link with the COVID-19 AstraZeneca vaccine, but investigations are ongoing," Kidd told a televised briefing.

He added that more details are expected to be known on Saturday.

Australia's Therapeutic Goods Administration (TGA), the medicine and therapeutic regulatory agency, has said previously that AstraZeneca vaccine was not associated with an increase in the overall risk of blood clots.

Comments

Comments are closed.